TY  - GEN
AU  - Kawakami,Y
AU  - Imamura,M
AU  - Ikeda,H
AU  - Suzuki,M
AU  - Arataki,K
AU  - Moriishi,M
AU  - Mori,N
AU  - Kokoroishi,K
AU  - Katamura,Y
AU  - Ezaki,T
AU  - Ueno,T
AU  - Ide,K
AU  - Masaki,T
AU  - Ohdan,H
AU  - Chayama,K
TI  - Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study
SN  - 1365-2893
PY  - 2017///1101
KW  - Aged
KW  - Aged, 80 and over
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Carbamates
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - epidemiology
KW  - Female
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Imidazoles
KW  - Incidence
KW  - Isoquinolines
KW  - Male
KW  - Middle Aged
KW  - Pilot Projects
KW  - Prospective Studies
KW  - Pyrrolidines
KW  - Renal Dialysis
KW  - Renal Insufficiency
KW  - complications
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Treatment Outcome
KW  - Valine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1111/jvh.12553
ER  -